Verve Therapeutics Ratios and Metrics

Market cap in millions NAD. Fiscal year is January - December.

Millions NAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jul '25 Jul 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Market Capitalization	748	763	763	691	648	599	Upgrade
Market Cap Growth	-3.65%	-0.06%	10.51%	6.58%	8.25%	4.85%	Upgrade
Enterprise Value	712	753	693	684	641	588	Upgrade
Last Close Price	16.70	17.03	17.04	15.42	14.47	13.36	Upgrade
PE Ratio	5.40	5.06	6.60	24.97	4.43	-	Upgrade
PS Ratio	5.15	4.84	6.29	21.52	4.23	-16.41	Upgrade
PB Ratio	0.51	0.49	0.55	0.60	0.61	0.71	Upgrade
P/TBV Ratio	0.51	0.49	0.55	0.60	0.61	0.71	Upgrade
P/OCF Ratio	55.15	52.62	126.84	132.64	132.91	402.90	Upgrade
EV/Sales Ratio	4.90	4.78	5.71	21.32	4.19	-	Upgrade
EV/EBIT Ratio	5.05	4.89	6.01	25.55	4.32	-	Upgrade
Asset Turnover	0.10	0.11	0.09	0.03	0.15	-	Upgrade
Quick Ratio	18.94	16.61	59.98	79.79	176.16	170.04	Upgrade
Current Ratio	58.78	28.08	117.82	130.34	414.01	253.61	Upgrade
Return on Equity (ROE)	9.84%	10.16%	8.74%	2.42%	14.74%	-4.47%	Upgrade
Return on Assets (ROA)	6.28%	6.48%	5.45%	1.46%	9.36%	-3.18%	Upgrade
Return on Capital (ROIC)	6.29%	6.49%	5.45%	1.46%	9.37%	-3.18%	Upgrade
Return on Capital Employed (ROCE)	9.60%	9.90%	8.40%	2.30%	14.00%	-	Upgrade
Earnings Yield	18.46%	19.75%	15.15%	4.00%	22.55%	-6.43%	Upgrade
Buyback Yield / Dilution	7.35%	-	-	-	-	-	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.